What's more, it addresses the FDA’s communications Using the applicant, the retention of documents that assist the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may transfer possession of the SE report back to a brand new applicant and electronic submission of the SE report and a